TY - JOUR
T1 - Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties
AU - Kong, Xiangqian
AU - Chen, Jie
AU - Xie, Wenbing
AU - Brown, Stephen M.
AU - Cai, Yi
AU - Wu, Kaichun
AU - Fan, Daiming
AU - Nie, Yongzhan
AU - Yegnasubramanian, Srinivasan
AU - Tiedemann, Rochelle L.
AU - Tao, Yong
AU - Chiu Yen, Ray Whay
AU - Topper, Michael J.
AU - Zahnow, Cynthia A.
AU - Easwaran, Hariharan
AU - Rothbart, Scott B.
AU - Xia, Limin
AU - Baylin, Stephen B.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/4/15
Y1 - 2019/4/15
N2 - UHRF1 facilitates the establishment and maintenance of DNA methylation patterns in mammalian cells. The establishment domains are defined, including E3 ligase function, but the maintenance domains are poorly characterized. Here, we demonstrate that UHRF1 histone- and hemimethylated DNA binding functions, but not E3 ligase activity, maintain cancer-specific DNA methylation in human colorectal cancer (CRC) cells. Disrupting either chromatin reader activity reverses DNA hypermethylation, reactivates epigenetically silenced tumor suppressor genes (TSGs), and reduces CRC oncogenic properties. Moreover, an inverse correlation between high UHRF1 and low TSG expression tracks with CRC progression and reduced patient survival. Defining critical UHRF1 domain functions and its relationship with CRC prognosis suggests directions for, and value of, targeting this protein to develop therapeutic DNA demethylating agents.
AB - UHRF1 facilitates the establishment and maintenance of DNA methylation patterns in mammalian cells. The establishment domains are defined, including E3 ligase function, but the maintenance domains are poorly characterized. Here, we demonstrate that UHRF1 histone- and hemimethylated DNA binding functions, but not E3 ligase activity, maintain cancer-specific DNA methylation in human colorectal cancer (CRC) cells. Disrupting either chromatin reader activity reverses DNA hypermethylation, reactivates epigenetically silenced tumor suppressor genes (TSGs), and reduces CRC oncogenic properties. Moreover, an inverse correlation between high UHRF1 and low TSG expression tracks with CRC progression and reduced patient survival. Defining critical UHRF1 domain functions and its relationship with CRC prognosis suggests directions for, and value of, targeting this protein to develop therapeutic DNA demethylating agents.
KW - UHRF1
KW - colorectal cancer prognosis
KW - domain functions
KW - maintenance DNA methylation
KW - next-generation DNA demethylating agents
KW - oncogenic properties
KW - tumor suppressor gene silencing
UR - http://www.scopus.com/inward/record.url?scp=85064085680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064085680&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2019.03.003
DO - 10.1016/j.ccell.2019.03.003
M3 - Article
C2 - 30956060
AN - SCOPUS:85064085680
SN - 1535-6108
VL - 35
SP - 633-648.e7
JO - Cancer cell
JF - Cancer cell
IS - 4
ER -